CIK 0001721484
- Emerging growth company
Longeveron Inc.
Sign in to watch- Ticker
- LGVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472174146
- Phone
- +1 305-302-7158
- Business address
- 1951 NW 7TH AVENUE, SUITE 520, MIAMI, FL, 33136
- Former names
- LONGEVERON LLC
- 4 Exercise or conversion Chief Scientific Officer acquired 30,000 shares (option exercise)
- 4 Other acquisition Chief Financial Officer acquired 5,000 shares (code O)
- 4 Exercise or conversion Chief Executive Officer acquired 10,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Director acquired 30,000 shares (option exercise)
- 4 Shares withheld for taxes Chief Executive Officer gave up 4,323 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel, Secretary gave up 767 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 3,081 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 4,292 shares (to pay taxes)
- 4 Grant or award Chief Financial Officer acquired 40,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Medical Officer acquired 30,000 shares (grant or award)
- 4 Shares withheld for taxes Chief Executive Officer gave up 3,819 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale CFO and Treasurer sold 23,532 shares at an average $3.47 ($81,541)
- 4 Shares withheld for taxes CFO and Treasurer gave up 752 shares (to pay taxes)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 4 Grant or award Director acquired 5,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 8 of 13 · 246 filings